InnaMed (1)

Using smart, at-home blood testing technology to enable personalized medicine

Security Type: SAFE
Categories: Other
Min Investment: $60
Location: Philadelphia, PA
Offering Date: April 30, 2019
Expected Close Date: August 01, 2019
Target Raise: $50.00K-$1.07M
Deal Notes: No discount

Company Description

Using smart, at-home blood testing technology to enable personalized medicine

Key Deal Facts

Smart, at-home blood testing device with several disease specific test cartridges
Y Combinator company that has raised $1M from leading Silicon Valley investors
Leadership team of strong technical founders and CEO and CMO with 30+ years of experience and multiple exits of eight- and nine-figures in the diagnostics industry
4 patents and 3 peer-reviewed publications covering the core technology
$400k in contracts with multiple high impact U.S. government agencies and a top 5 global pharma company
Initial focus in the $3B+ cardiac diagnostics market segment with plans to expand into the broader $50B+ lab testing and patient monitoring markets

Use of Proceeds

Campaign marketing expenses, salaries and wages, technology and development

Management Team / Advisory Board Bios

see offering page for details

Deal Notes

No discount

Amount Raised : $1,070,000

Reveal the Score by Voting

＿

ⓘ

Business Idea

ⓘ

Business Traction

ⓘ

Management Team

ⓘ

Valuation

Security Description

A SAFE is an agreement between you—the investor—and the company in which the company promises to give you a future equity stake based on the amount you invested. It also involves some kind of a triggering event that must take place in order for you to get your future equity stake. Be careful as you may only get equity if a particular event is triggered.